Kobayashi

BioPhy Appoints Scott Kobayashi as Senior Vice President of Sales to Accelerate Strategic Expansion

Retrieved on: 
Tuesday, April 2, 2024
Health, Technology, Health Technology, General Health, Artificial Intelligence, Pharmaceutical, Biotechnology, Organization, Growth, Pfizer, Fluor, Spark Therapeutics, Patient, AI, EY, Senior, Kobayashi, Clinical trial, Therapy, Drug development, Ecosystem, FDA, Pharmaceutical industry

BioPhy, an innovative AI drug development platform, today announced the appointment of Scott Kobayashi as Senior Vice President of Sales.

Key Points: 
  • BioPhy, an innovative AI drug development platform, today announced the appointment of Scott Kobayashi as Senior Vice President of Sales.
  • In this newly created role, Kobayashi will spearhead BioPhy's expansion in life sciences, public-private healthcare partnerships, financial services, and the public domain.
  • Prior to this, he held pivotal consulting positions at pharmaceutical industry giants Pfizer, Genentech, and Fluor, specializing in business expansion, partnerships, and development strategies.
  • “BioPhy has set itself apart from other biotech solutions with remarkable results in predicting and guiding clinical trial success.

KOOL 'N' SOOTHE NIGHT COOLING SPRAY - BACK IN STOCK ON AMAZON AFTER STRONG INITIAL DEMAND

Retrieved on: 
Thursday, August 3, 2023
Male, Kobayashi, Atmosphere, Hope, Sensation, Amazon (company), Kool, Weather, System, Perspiration, Female, Heating, ventilation, and air conditioning, Propane

LONDON, Aug. 3, 2023 /PRNewswire/ -- Kobayashi Healthcare Europe Ltd is thrilled to announce that the Kool 'N' Soothe Night Cooling Spray, which launched on Amazon.co.uk in June 2023, is back in stock after seeing exceptional demand in its initial release.

Key Points: 
  • LONDON, Aug. 3, 2023 /PRNewswire/ -- Kobayashi Healthcare Europe Ltd is thrilled to announce that the Kool 'N' Soothe Night Cooling Spray, which launched on Amazon.co.uk in June 2023, is back in stock after seeing exceptional demand in its initial release.
  • The product, from the makers of the Kool 'N' Soothe Migraine cooling gel sheets, offers a new solution to the increasingly hot UK summer nights.
  • With a suggested retail price of £7.99 for a 100ml bottle, Kool 'N' Soothe Night Cooling Spray is a cost-effective way for UK consumers to stay cool through hot, muggy nights and heat waves.
  • N=1000, male & female 20-59, UK nation
    Link to purchase/ more information:
    Kool 'n' Soothe Night Cooling Spray is available as a 100ml spray bottle with a recommended retail price of £7.99.

HEINZ® Launches Movement Against Mistreatment of Hot Dogs; Rallies for Justice at World’s Largest Hot Dog Eating Contest

Retrieved on: 
Tuesday, July 4, 2023
Men, Entertainment, Family, Supermarket, Consumer, Food, Beverage, General Entertainment, Teens, Retail, Children, Other Consumer, Women, Nathan's Hot Dog Eating Contest, Partnership, Kobayashi, Dog, Light, Multimedia, Movement, Hot dog, Brand community, Love, Water, Condiment, Fast food, D.C

Just minutes after the world’s most famous Hot Dog Eating Contest, the brand and six-time Hot Dog-Eating Contest Champion, Takeru Kobayashi, will rally for justice by giving runners-up a chance at redemption.

Key Points: 
  • Just minutes after the world’s most famous Hot Dog Eating Contest, the brand and six-time Hot Dog-Eating Contest Champion, Takeru Kobayashi, will rally for justice by giving runners-up a chance at redemption.
  • View the full release here: https://www.businesswire.com/news/home/20230704993878/en/
    HEINZ and Kobayashi partner against the mistreatment of hot dogs, launching the ‘Hot Dogs Are Not a Contest’ movement in honor of the world’s most-known Hot Dog Eating Contest.
  • I am done with Hot Dog Eating Contests, and I encourage contestants and fans everywhere to see the light – hot dogs aren’t hot dogs without condiments.”
    Immediately following The Hot Dog Eating Contest, HEINZ will give losing finalists a chance at redemption – by simply enjoying a hot dog properly – dressed in HEINZ condiments.
  • Promotion begins on 7/4/23 immediately following the The Hot Dog Eating Contest and ends at 11:59 p.m ET on 7/14/23.

Dr.Evidence® Appoints Ken Kobayashi, MD, FACP to its Medical Strategy Advisory Board

Retrieved on: 
Tuesday, June 6, 2023
Software, Research, General Health, Pharmaceutical, Oncology, Technology, Artificial Intelligence, Health Technology, Science, Biotechnology, Other Science, Health, MSAB, Kobayashi, Drug development, Swansea University Medical School, Chair, MB, FACP, AB, Janssen, Multimedia, Doctor of Philosophy, AstraZeneca, Bachelor of Science, National Cancer Institute, Criticism of the Food and Drug Administration, SCM, Bachelor of Medicine, Bachelor of Surgery, Novartis, Daiichi Sankyo, MPH, Feinberg School of Medicine, BA, Food, Pfizer, Medical device, Pharmaceutical industry, Washington University in St. Louis, MD

Dr.Evidence is pleased to announce the appointment of Ken Kobayashi, MD, FACP to the MSAB.

Key Points: 
  • Dr.Evidence is pleased to announce the appointment of Ken Kobayashi, MD, FACP to the MSAB.
  • He joins Chair, Calum MacRae, MB, ChB, PhD, BSc, and members, Michael Klag, MD, MPH, Frank Rockhold, PhD, ScM, BA, and David Tovey, MD.
  • View the full release here: https://www.businesswire.com/news/home/20230606005160/en/
    Dr.Evidence® Appoints Ken Kobayashi, MD, FACP to its Medical Strategy Advisory Board.
  • Kobayashi received his MD from Northwestern University Medical School, Chicago, IL, and his AB from Washington University, St. Louis, MO.

Public advisory - Unauthorized Kobayashi eye washes and Sante FX eye drops seized from "Kiokii and…" store in Mississauga, ON, and removed from website because they may pose serious health risks

Retrieved on: 
Monday, May 15, 2023
Glaucoma, Retinal detachment, DIN, Kobayashi, Bleeding, Allergy, Prescription drug, Pharmacy, Neostigmine, Eye, Iris cyst, Health Canada, Cataract, Absorption, Sale, Plasma protein binding, Muscle weakness, Nose, NPN, Suite, Dizziness, Aminocaproic acid, Blood, Drug identification number, Nausea, Natural product, Health, Headache, Rash, Safety, Dietary supplement

Health Canada is warning consumers about unauthorized Kobayashi eye washes and Sante FX eye drops seized from the store "Kiokii and…" (actual store name) in Mississauga (719 Central Pkwy W, Suite 211), Ontario, and removed from online sale.

Key Points: 
  • Health Canada is warning consumers about unauthorized Kobayashi eye washes and Sante FX eye drops seized from the store "Kiokii and…" (actual store name) in Mississauga (719 Central Pkwy W, Suite 211), Ontario, and removed from online sale.
  • The products were seized because they are unauthorized and labelled to contain prescription drug ingredients and may pose serious health risks.
  • Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks.
  • In addition, absorption into the nose via the tear duct may cause serious cardiac and respiratory side effects.

Public advisory - Unauthorized Kobayashi eye washes and Sante FX eye drops seized from "Kiokii and…" store in Mississauga, ON, and removed from website because they may pose serious health risks

Retrieved on: 
Friday, May 12, 2023
Glaucoma, Retinal detachment, DIN, Kobayashi, Bleeding, Allergy, Prescription drug, Pharmacy, Neostigmine, Eye, Iris cyst, Health Canada, Cataract, Absorption, Sale, Plasma protein binding, Muscle weakness, Nose, NPN, Suite, Dizziness, Aminocaproic acid, Blood, Drug identification number, Nausea, Natural product, Health, Headache, Rash, Safety, Dietary supplement

Health Canada is warning consumers about unauthorized Kobayashi eye washes and Sante FX eye drops seized from the store "Kiokii and…" (actual store name) in Mississauga (719 Central Pkwy W, Suite 211), Ontario, and removed from online sale.

Key Points: 
  • Health Canada is warning consumers about unauthorized Kobayashi eye washes and Sante FX eye drops seized from the store "Kiokii and…" (actual store name) in Mississauga (719 Central Pkwy W, Suite 211), Ontario, and removed from online sale.
  • The products were seized because they are unauthorized and labelled to contain prescription drug ingredients and may pose serious health risks.
  • Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks.
  • In addition, absorption into the nose via the tear duct may cause serious cardiac and respiratory side effects.

Canon U.S.A. Continues To Support Annual Japan Center Essay Competition Awards Program

Retrieved on: 
Monday, April 25, 2022
News, Canon Inc., Awareness, Politics, Middle school, Culture, Fiorello H. LaGuardia High School, Social responsibility, Research, IFI, Magic, Religion, Education, Program, Goal, RSS, Fortune, United States Patent and Trademark Office, Stony Brook University, Student, Japan Center for Michigan Universities, Company, Patent, Kobayashi, Philosophy, Fiorello, Solution, General manager, Music, History, NYSE, Multimedia, Partnership, School, Senior, Japan Center, Medicine, Pharmaceutical industry, Management, Tutoring, Canon

MELVILLE, N.Y., April 25, 2022 /PRNewswire/ -- Extending its commitment towards empowering students and supporting education, Canon U.S.A., Inc., a leader in digital imaging solutions, proudly sponsored and participated in the 17th Annual Japan Center Essay Competition Awards Program on April 23.

Key Points: 
  • The essay competition, organized by the Japan Center at Stony Brook University, honoredseven students for work that demonstrated their awareness and understanding of the Japanese culture.
  • Canon U.S.A., Inc. and the Japan Center at Stony Brook University have a longstanding partnership, which began in 2005 with former President and Chief Executive Officer of Canon U.S.A., Inc., the late Mr. Kinya Uchida.
  • "The essay competition provides a means to promote education and research and develop a better understanding of cultural activities related to Japan.
  • The first Japan Center Essay Competition, organized by Stony Brook University in New York and supported by Canon U.S.A., was held during the 2005-2006 school year.

BlackSand Capital is Bullish on Hawaii

Retrieved on: 
Thursday, August 19, 2021
Finance, Professional Services, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Industry, Blacksand, Alder Street food cart pod, Acquisition, American City Business Journals, Tourism, Heart, Investment, Multimedia, Wood, Overalls, Risk, Kobayashi, Wind, DFS, CEO, Sale, Housing, News, Island, Financial services, Management, Hotel, Real estate, Property management

BlackSand Capital, a Hawaii specialist private equity firm, is bullish on Hawaiis recovery in the post-pandemic world.

Key Points: 
  • BlackSand Capital, a Hawaii specialist private equity firm, is bullish on Hawaiis recovery in the post-pandemic world.
  • Kobayashi, Chairman and CEO of BlackSand Capital, shown here at the Kaimana Beach Hotel in Waikiki, Hawaii.
  • However, Hawaii is about more than tourism, and for decades, BlackSand Capitals Chairman and CEO, B.J.
  • Were a private equity firm, were owned here in Hawaii and our investment dollars, 80% of them, stay in Hawaii.